Cas:79079-18-8 Lanthanum(III) oxalate hydrate manufacturer & supplier

We serve Chemical Name:Lanthanum(III) oxalate hydrate CAS:79079-18-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Lanthanum(III) oxalate hydrate

Chemical Name:Lanthanum(III) oxalate hydrate
CAS.NO:79079-18-8
Synonyms:EINECS 208-656-1;lanthanum (iii) oxalate;MFCD00150540
Molecular Formula:C6H20La2O22
Molecular Weight:722.02100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:250.10000
Exact Mass:721.85700
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN3288
Packing Group:III


Contact us for information like EINECS 208-656-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00150540 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,lanthanum (iii) oxalate Use and application,MFCD00150540 technical grade,usp/ep/jp grade.


Related News: Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. Lanthanum(III) oxalate hydrate manufacturer The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Lanthanum(III) oxalate hydrate supplier The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses. Lanthanum(III) oxalate hydrate vendor Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. Lanthanum(III) oxalate hydrate factory The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.